Abbott has agreed to pay nearly $385 million to resolve alleged false claims involving infant formula made at its Michigan facility. The settlement follows the company’s 2022 recall and plant closure amid contamination concerns. Abbott maintains that no distributed infant formula tested positive for Cronobacter and says government testing found no bacteria in unopened products.
Post Content
Tim Seifert delivered an impressive performance with 93 runs in the final T20I against India,…
China is currently testing an innovative uncrewed trimaran submarine that boasts an arsenal of missiles,…